These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28814231)

  • 21. Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings.
    Semengue ENJ; Armenia D; Inzaule S; Santoro MM; Dambaya B; Takou D; Teto G; Nka AD; Yagai B; Fabeni L; Chenwi C; Angong Beloumou G; Djupsa Ndjeyep SC; Colizzi V; Perno CF; Ceccherini-Silberstein F; Fokam J
    J Antimicrob Chemother; 2021 Apr; 76(5):1277-1285. PubMed ID: 33501504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors.
    Brenner BG; Lowe M; Moisi D; Hardy I; Gagnon S; Charest H; Baril JG; Wainberg MA; Roger M
    J Med Virol; 2011 May; 83(5):751-9. PubMed ID: 21360548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analyses of HIV-1 integrase gene sequences among treatment-naive patients in the Eastern Cape, South Africa.
    Onoriode Digban T; Chucks Iweriebor B; Chikwelu Obi L; Nwodo U; Ifeanyi Okoh A
    J Med Virol; 2020 Aug; 92(8):1165-1172. PubMed ID: 31889319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 drug resistance mutations detection and HIV-1 subtype G report by using next-generation sequencing platform.
    Gholami M; Rouzbahani N; Samiee S; Tayeri K; Ghorban K; Dehkharghani AD; Gholami AA; Moshiri F; Sattari A; Dadmanesh M; Mohraz M
    Microb Pathog; 2020 Sep; 146():104221. PubMed ID: 32360523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural polymorphisms of human immunodeficiency virus type 1 integrase and inherent susceptibilities to a panel of integrase inhibitors.
    Low A; Prada N; Topper M; Vaida F; Castor D; Mohri H; Hazuda D; Muesing M; Markowitz M
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4275-82. PubMed ID: 19651917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of integrase region polymorphisms in HIV type 1 CRF06_cpx viruses in treatment-naive patients in Estonia.
    Avi R; Huik K; Sadam M; Karki T; Krispin T; Ainsalu K; Paap P; Schmidt J; Nikitina N; Lutsar I
    AIDS Res Hum Retroviruses; 2010 Oct; 26(10):1109-13. PubMed ID: 20849300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current status of HIV-1 diversity and drug resistance monitoring in the former USSR.
    Bobkova M
    AIDS Rev; 2013; 15(4):204-12. PubMed ID: 24192601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pre-Treatment Integrase Inhibitor Resistance and Natural Polymorphisms among HIV-1 Subtype C Infected Patients in Ethiopia.
    Arimide DA; Szojka ZI; Zealiyas K; Gebreegziabxier A; Adugna F; Sasinovich S; Björkman P; Medstrand P
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pre-treatment integrase inhibitor resistance is uncommon in antiretroviral therapy-naive individuals with HIV-1 subtype A1 and D infections in Uganda.
    McCluskey SM; Kamelian K; Musinguzi N; Kigozi S; Boum Y; Bwana MB; Muzoora C; Brumme ZL; Carrington M; Carlson J; Foley B; Hunt PW; Martin JN; Bangsberg DR; Harrigan PR; Siedner MJ; Haberer JE; Lee GQ
    AIDS; 2021 Jun; 35(7):1083-1089. PubMed ID: 33635845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 Integrase Resistance among Highly Antiretroviral Experienced Patients from Morocco.
    Alaoui N; El Alaoui MA; El Annaz H; Farissi FZ; Alaoui AS; El Fahime E; Mrani S
    Intervirology; 2019; 62(2):65-71. PubMed ID: 31307042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of integrase strand transfer inhibitor (INSTIs) resistance mutations in Henan Province, China (2018-2020).
    Yang Z; Yang X; Deng X; Wei S; Liu J; Ma J; Zhao Q; Huo Y
    Infection; 2021 Dec; 49(6):1195-1202. PubMed ID: 34279816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of Integrase Strand Transfer Inhibitors Resistance Mutations in Integrase Strand Transfer Inhibitors-Naive and -Experienced HIV-1 Infected Patients: A Single Center Experience.
    De Francesco MA; Izzo I; Properzi M; Gargiulo F; Caccuri F; Quiros-Roldan E; Castelli F; Caruso A; Focà E
    AIDS Res Hum Retroviruses; 2018 Jul; 34(7):570-574. PubMed ID: 29631420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance comparison of an in-house integrase genotyping assay versus the ViroSeq™ Integra48, and study of HIV-1 integrase polymorphisms in Hong Kong.
    To SW; Chen JH; Wong KH; Chan KC; Ng HM; Wu H; Lam JT; Yam WC
    J Clin Virol; 2013 Sep; 58(1):299-302. PubMed ID: 23886504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating HIV-1 Integrase Genotypes in Tanzania: Implication on the Introduction of Integrase Inhibitors-Based Antiretroviral Therapy Regimen.
    Masoud S; Kamori D; Barabona G; Mahiti M; Sunguya B; Lyamuya E; Ueno T
    AIDS Res Hum Retroviruses; 2020 Jun; 36(6):539-543. PubMed ID: 32126792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of HIV-1 integrase genotypes and polymorphisms among integrase inhibitors-based antiretroviral treatment naïve patients in South Sudan.
    Giovanetti M; Farcomeni S; Sernicola L; Virtuoso S; Fontanelli Sulekova L; Maggiorella MT; Buttò S; Taliani G; Ciccozzi M; Borsetti A
    J Med Virol; 2022 Jul; 94(7):3320-3327. PubMed ID: 35277871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low level of HIV-1C integrase strand transfer inhibitor resistance mutations among recently diagnosed ART-naive Ethiopians.
    Kiros M; Tefera DA; Andualem H; Geteneh A; Tesfaye A; Woldemichael TS; Kidane E; Alemayehu DH; Maier M; Mihret A; Abegaz WE; Mulu A
    Sci Rep; 2023 Apr; 13(1):6546. PubMed ID: 37085698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analyses of HIV-1 integrase sequences prior to South African national HIV-treatment program and available of integrase inhibitors in Cape Town, South Africa.
    Brado D; Obasa AE; Ikomey GM; Cloete R; Singh K; Engelbrecht S; Neogi U; Jacobs GB
    Sci Rep; 2018 Mar; 8(1):4709. PubMed ID: 29549274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of HIV-1 drug resistance in Eastern European and Central Asian countries.
    Kirichenko A; Kireev D; Lopatukhin A; Murzakova A; Lapovok I; Saleeva D; Ladnaya N; Gadirova A; Ibrahimova S; Safarova A; Grigoryan T; Petrosyan A; Sarhatyan T; Gasich E; Bunas A; Glinskaya I; Yurovsky P; Nurov R; Soliev A; Ismatova L; Musabaev E; Kazakova E; Rakhimova V; Pokrovsky V
    PLoS One; 2022; 17(1):e0257731. PubMed ID: 35061671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resistance to HIV Integrase Inhibitors: About R263K and E157Q Mutations.
    Charpentier C; Descamps D
    Viruses; 2018 Jan; 10(1):. PubMed ID: 29346270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrase Strand Transfer Inhibitors (INSTIs) Resistance Mutations in HIV-1 Infected Turkish Patients.
    Sayan M; Gündüz A; Ersöz G; İnan A; Deveci A; Özgür G; Sargın F; Karagöz G; İnci A; İnan D; Ülçay A; Karaoğlan I; Kaya S; Kutlu SS; Süer K; Çağatay A; Akalın H
    HIV Clin Trials; 2016 May; 17(3):109-13. PubMed ID: 27125365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.